study of Apixaban in netherlands
Antiplatelets, & fibrinolytics
Guidelines for the prevention of stroke in women 2014
Title Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation Clinical Trial Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with.
AHA/ASA Guideline Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals.
Transcatheter LAA Occlusion Ahmed A. Khattab Cardiology Bern – Switzerland.
Percutaneous Closure of the Left Atrial Appendage versus Warfarin Therapy for Prevention of Stroke in Patients with Atrial Fibrillation: A Randomized Non-Inferiority.
Matthew W. Sherwood, Anne Hellkamp, Manesh R. Patel, Jonathan P. Piccini, Yuliya Lokhnygina, James Douketis, Richard C. Becker, Kenneth W. Mahaffey, Keith.
Debbie L. Cardell, MD Div Gen Med UTHSCSA2/29/08 Anticoagulation Debbie L. Cardell, MD Asst. Clinical Prof of Medicine Medical Director UHC-D Anticoagulation.
NOAC but NICE Conference 16 th July 2013. Stroke Prevention in Atrial Fibrillation. NICE, NOACS and the future Dr John Duffy Stroke Consultant LTC Clinical.
ER Direct Case: Management of Atrial Fibrillation and Post- Treatment Bleeding in Patient with Prior TIA ACS and Thrombosis in the Emergency Setting.
Kenneth W. Mahaffey, MD and Keith AA Fox, MB ChB on behalf of the ROCKET AF Investigators Rivaroxaban Once-daily oral direct factor Xa inhibition Compared.